Logo
ReMedium 50ml Body Filler

ReMedium 50ml Body Filler

ReMedium

Aesthetic Medicine Products
  • Manufactured in South Korea by Forever18 International Co., Ltd, which promotes ReMedium as a high Quality hyaluronic acid filler line made in a medical device manufacturing environment; other ReMedium body filler products (e.g. ReMedium Advance H 10mL Body Filler) are described by distributors as KFDA Approved and CE Certified, indicating a regulatory framework consistent with CE Marked Class III medical devices, although specific CE certificate details for ReMedium 50ml Body Filler are not individually listed in public sources.
  • Produced using proprietary cross Linking and microbead technologies (including MCL – Multi Stage Crosslinking – referenced across the ReMedium filler range) aimed at ensuring high purity, stability and safety of the hyaluronic acid gel.
  • Manufacturer communications emphasise adherence to international quality and safety standards (e.g. materials in line with European Pharmacopoeia for other ReMedium body fillers), though precise standard numbers (such as ISO 13485 or GMP certifications) are not explicitly stated for this specific product in publicly accessible documentation.
Hyaluronic acid body dermal filler

Description

ReMedium 50ml Body Filler (often referred to as ReMedium 50 Body Filler) is a high-capacity hyaluronic acid body filler designed for non-surgical body contouring and volume restoration. Manufactured in South Korea by Forever18 International Co., Ltd (ReMedium Korea), this monophasic, highly cohesive HA gel is supplied in a 50 ml vial and is intended for use by trained medical professionals in aesthetic and body-contouring procedures. The product contains 24 mg/cc cross-linked hyaluronic acid and is formulated to provide strong volumising power, high elasticity and adhesion to tissues, enabling three-dimensional contouring and enlargement of selected body areas. According to the manufacturer, it contains zero impurities and is produced with advanced microbead and monophasic technology to achieve high viscosity and long-lasting effects. ReMedium 50 Body Filler is used for sculpting and enhancing areas such as hips, buttocks, breasts (non-implant, soft-tissue contouring only where locally permitted), calves, knees, elbows and intimate areas, delivering natural-looking contours and improved skin elasticity with effects that can last up to approximately 18–24 months when properly administered.

Bnefits

  • High-capacity 50 ml body filler designed specifically for body contouring and volumising large areas of soft tissue.
  • Contains 24 mg/cc cross-linked hyaluronic acid, higher than many competing body fillers, providing strong and durable volumising effects.
  • Monophasic hyaluronic acid gel with high particle density, cohesion and adhesion, supporting stable three-dimensional body contouring.
  • Manufacturer states the filler contains zero detectable impurities and is produced using advanced purification and manufacturing technology.
  • High viscosity and elasticity help the gel maintain shape, resist migration and provide long-lasting results.
  • Intended for sculpting multiple body areas, including hips, buttocks, breasts (soft-tissue contouring where allowed), thighs, calves, knees, elbows and intimate areas, giving practitioners flexibility in treatment planning.
  • Natural-looking effect with smooth contours and improved skin elasticity when used appropriately by qualified practitioners.
  • Long duration of effect, typically reported in the range of 18–24 months in clinical aesthetic practice, contributing to patient satisfaction and cost-effectiveness.
  • Part of the broader ReMedium portfolio of Korean HA fillers and body fillers, which are positioned as safe, removable, high-viscosity and hydrophilic products designed for global aesthetic markets.

Indications

  • Professional, non-surgical body contouring and volumisation performed by trained healthcare professionals.
  • Enhancement and reshaping of body areas such as hips and buttocks (gluteal augmentation and contouring with soft-tissue filler).
  • Soft-tissue contouring of breasts (non-implant, off-label or as locally permitted) to improve volume and upper pole fullness.
  • Volumisation and contour correction of calves, thighs, knees and elbows to improve overall silhouette and symmetry.
  • Correction of body asymmetries and irregularities (for example, contour defects after liposuction) via soft-tissue augmentation.
  • Improvement of skin elasticity and appearance in selected body regions through volumising HA gel support.
  • Soft-tissue enhancement in male and female intimate areas where such use is medically and legally permitted and performed by appropriately qualified specialists.

Composition

  • Cross-linked hyaluronic acid gel, concentration approximately 24 mg/cc (24 mg/mL) as stated by the manufacturer.
  • Monophasic, highly purified hyaluronic acid microbead technology designed for high viscosity, elasticity and cohesion.
  • Water for injection and standard excipients used in cross-linked HA dermal filler formulations (exact full excipient list not publicly disclosed).
  • No lidocaine: ReMedium 50 Body Filler is supplied without local anaesthetic; analgesia/anaesthesia must be provided separately according to clinical practice.

Formulation

  • Non-animal, cross-linked hyaluronic acid body filler.
  • Monophasic, highly cohesive and high-viscosity gel with microbead-based structure for long-lasting volume and three-dimensional contouring.
  • Hyaluronic acid concentration: 24 mg/cc (manufacturer data).
  • Cross-linking rate around 10% for ReMedium 50 Body Filler (as per manufacturer comparison chart).
  • Supplied as a viscous gel requiring large-bore needles/cannulas for withdrawal and injection (18G for vial withdrawal and typically 16G–18G for injection, for professional use only).
  • Intended injection plane: deep subcutaneous or supraperiosteal plane in body tissues, depending on treatment area and professional judgement (exact technique per official instructions for use and training).

Packaging

  • Primary container: 1 x 50 ml vial (or bottle) containing ReMedium 50 Body Filler hyaluronic acid gel.
  • Outer packaging: branded ReMedium 50 Body Filler carton with product name, volume (50 ml), manufacturer details and basic regulatory information.
  • The vial is sealed with an aluminium cap and rubber stopper; filler is withdrawn into a separate large-volume syringe (e.g. 10 ml) for injection using appropriate large-bore needles/cannulas as per manufacturer guidance.
  • Intended for single-patient use; any unused product after a session should be discarded in accordance with local regulations and the manufacturer’s instructions.

Usage

  • For professional use only: ReMedium 50ml Body Filler is intended solely for use by trained and appropriately licensed healthcare professionals with expertise in injectable body contouring procedures.
  • Pre-treatment assessment: Evaluate patient medical history, indications, expectations and contraindications. Obtain informed consent, including discussion of potential risks, benefits, alternatives and the temporary nature of the filler.
  • Preparation: Perform treatment in an appropriate clinical environment using aseptic technique. Clean and disinfect the treatment area and access sites according to local infection-control protocols.
  • Product handling: Remove the aluminium cap and rubber stopper from the 50 ml vial following manufacturer instructions. Using a suitable large-volume syringe (e.g. 10 ml) with an 18G needle, withdraw the required amount of gel from the vial. Transfer to an injection cannula/needle appropriate for deep body filler placement (commonly 16G–18G) according to your training and manufacturer recommendations.
  • Administration: Inject slowly into the appropriate deep tissue plane (typically deep subcutaneous fat) in the targeted body area, using established body-filler techniques (e.g. linear threading, fanning, layering) that you are trained in. Avoid high-risk anatomical zones, superficial placement, and any intravascular injection. Aspirate in accordance with your local practice standards and training where appropriate.
  • Shaping: After each bolus or thread of filler, gently mold and contour the treated area externally to achieve the desired three-dimensional shape and smooth surface transition while avoiding undue pressure that may displace the gel.
  • Dosage: Total volume per session and per area should be determined by the treating practitioner based on patient characteristics, anatomy and treatment plan, respecting any maximum volumes and spacing recommendations provided in the manufacturer’s instructions for use.
  • Post-treatment care: Provide the patient with written aftercare instructions, which typically include avoiding pressure, trauma, intense exercise, heat exposure (such as saunas) and certain sleeping positions for a defined period, and monitoring for signs of complications. Advise on when to return for follow-up.
  • Follow-up: Schedule follow-up visits to assess symmetry, integration of the filler and patient satisfaction, and to decide if touch-up treatments are needed. Avoid excessive overcorrection in early sessions.
  • Emergency protocol: Practitioners should have appropriate protocols, materials and medications available to manage potential adverse events or complications of HA body fillers (e.g. vascular compromise, infection, inflammatory reactions), including immediate referral pathways if needed.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid or to any of the components of the formulation.
  • History of severe or multiple allergies, or anaphylactic reactions to injectable products, unless carefully evaluated and monitored by a specialist.
  • Presence of active skin infection, inflammation or dermatological disease at or near the intended injection sites (e.g. active cellulitis, dermatitis, herpes lesions).
  • Systemic infection, fever or uncontrolled systemic disease at the time of treatment.
  • Tendency to develop hypertrophic scars or keloids, or history of abnormal wound healing, particularly in the intended treatment area, unless the risk–benefit has been assessed by a specialist.
  • Known autoimmune diseases or immunosuppressive conditions where injectable fillers may pose increased risk, unless used under the care of an experienced physician after careful consideration.
  • Pregnancy and breastfeeding, as safety in these populations has not been established.
  • Patients with untreated coagulation disorders or on significant anticoagulant/antiplatelet therapy where the risk of bleeding or bruising is unacceptable.
  • Any contraindications stated in the official ReMedium 50 Body Filler instructions for use, including off-label applications not supported by local regulations.

Adverse Effects

  • Common, usually transient reactions at the injection site such as redness (erythema), swelling, pain, tenderness, warmth, itching, bruising or mild firmness/lumps.
  • Temporary asymmetry or irregular contour due to uneven distribution or early post-treatment swelling, typically managed with massage or minor correction.
  • Nodules, palpable lumps or overcorrection if product is placed unevenly or in excessive amounts; may require professional management.
  • Infection at the injection site or deeper tissues, potentially requiring antibiotics and medical/surgical intervention.
  • Inflammatory or hypersensitivity reactions, including prolonged redness, swelling or induration; rare delayed immune-mediated reactions are possible with HA fillers.
  • Vascular compromise, including arterial or venous occlusion leading to ischemia, tissue necrosis or, in very rare and severe cases, embolic events; urgent recognition and management by an experienced physician are critical.
  • Changes in sensation (hypoesthesia or dysesthesia) or pain related to nerve irritation or compression.
  • Migration of the filler or contour irregularities over time, especially if injected inappropriately or subjected to significant external pressure.
  • As with all injectable HA fillers, there is a theoretical risk of granuloma formation or long-term foreign body reactions, though these events are uncommon.

Storage Conditions

  • Store in a cool, dry place at a controlled room temperature typically between 2°C and 25°C, away from direct sunlight and heat sources, as per manufacturer recommendations for ReMedium HA fillers.
  • Do not freeze; freezing may damage the hyaluronic acid gel structure.
  • Keep the vial in its original packaging until use to protect from light and contamination.
  • Do not use the product after the expiry date printed on the package.
  • Store out of the reach of children and unauthorised persons.
  • Once the vial has been opened and product withdrawn for a treatment session, any remaining unused gel should not be stored for later use and must be discarded according to local clinical waste regulations and the manufacturer’s instructions.

Duration

The manufacturer and multiple distributors report that the volumising and contouring effects of ReMedium 50ml Body Filler typically last around 18\u201324 months, although actual duration depends on factors such as treated area, injection technique, patient metabolism, lifestyle and follow-up regimen.

Onset

Volumising and contouring effects are visible immediately after injection, with the final aesthetic outcome typically evaluated after initial swelling and post-procedural reactions resolve over the following days to weeks.

Browse more Aesthetic Medicine Products

Top Treatments

Top Cities in the UK